Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case. (2023)
Attributed to:
New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.01.23.477397
PubMed Identifier: 35118468
Publication URI: http://europepmc.org/abstract/MED/35118468
Type: Journal Article/Review
Parent Publication: bioRxiv : the preprint server for biology
ISSN: 2692-8205